Mutual, Hikma Settle Suit Over Unapproved Gout Drug
U.K.-based Hikma Pharmaceuticals PLC's U.S. unit has settled a lawsuit with Mutual Pharmaceutical Co. Inc. over the gout treatment Colcrys, agreeing to stop selling a competing version of the medication until...To view the full article, register now.
Already a subscriber? Click here to view full article